Now showing items 31-40 of 2258
Specific components found in circulating immune complexes (CIC) in paracoccidioidomycosis
Circulating immune complexes (CIC) from 15 paracoccidioidomycosis (PCM) patient sera and from 20 healthy control sera were analysed. After CIC precipitation, solubilization and acid treatment, only a little reactivity to ...
Monoclonal Antibody Therapeutics As Potential Interferences On Protein Electrophoresis And Immunofixation
(WALTER DE GRUYTER GMBHBERLIN, 2016)
Neutralizing monoclonal antibodies to fight HIV-1 : on the threshold of success
Anti-human immunodeficiency virus type-1 (anti-HIV-1) neutralizing monoclonal antibodies are broadening the spectrum of pre- and post-exposure treatment against HIV-1. A better understanding of how these antibodies develop ...
Uso del rituximab(anticuerpo monoclonal anti-CD20) en lupus eritematoso sistémico refractario a tratamiento: Caso clínico
(Sociedad Médica de Santiago, 2005)
An anti-human recombinant tumor necrosis factor alpha (TNFα) monoclonal antibody recognizes an epitope in feline TNFα
(EDP Sciences, 2003)
It is likely that the murine response to human recombinant TNFα (hrTNFα) may generate antibodies (Ab) to epitopes present in TNFα from other species. Here, we demonstrate that F5 anti-hrTNFα monoclonal antibody (mAb) ...
Construction of an immunotoxin by linking a monoclonal antibody against the human epidermal growth factor receptor and a hemolytic toxin
(Sociedad de Biología de Chile, 2007)